Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study

Central Effects of Botulinum Neurotoxin—Evidence from Human Studies

(2019) David Weise et al.   Toxins

Botulinum toxin treatment of pain syndromes –an evidence based review

(2018) Yasaman Safarpour et al.   TOXICON

Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons

(2018) Matteo Caleo et al.   JOURNAL OF NEUROSCIENCE

RETRACTED

(2017) Gang Li et al.   MEDICINE

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology

(2017) Marco Pirazzini et al.   PHARMACOLOGICAL REVIEWS

Botulinum toxin type A for neuropathic pain in patients with spinal cord injury

(2016) Zee-A Han et al.   ANNALS OF NEUROLOGY

Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial

(2016) Nadine Attal et al.   LANCET NEUROLOGY

Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons

(2016) Ewa Bomba-Warczak et al.   Cell Reports

Intraoral administration of botulinum toxin for trigeminal neuropathic pain

(2016) Alberto Herrero Babiloni et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses

(2016) Thomas Shackleton et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial

(2015) Jean-Michel Gracies et al.   LANCET NEUROLOGY

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

(2014) L Shaw et al.   HEALTH TECHNOLOGY ASSESSMENT

Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial

(2014) Haifeng Zhang et al.   JOURNAL OF HEADACHE AND PAIN

Botulinum toxin A, brain and pain

(2014) Ivica Matak et al.   PROGRESS IN NEUROBIOLOGY

Botulinum Toxin A in Postherpetic Neuralgia

(2013) Zoe Apalla et al.   CLINICAL JOURNAL OF PAIN

Acute Treatment of Trigeminal Neuralgia With Onabotulinum Toxin A

(2013) Carlos Zúñiga et al.   CLINICAL NEUROPHARMACOLOGY

Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?

(2013) Hatem S Shehata et al.   JOURNAL OF HEADACHE AND PAIN

Botulinum toxins: Mechanisms of action, antinociception and clinical applications

(2013) Anthony Wheeler et al.   TOXICOLOGY

Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial

(2012) Chuan-Jie Wu et al.   CEPHALALGIA

Learning from the past: historical aspects of bacterial toxins as pharmaceuticals

(2012) Sabine Pellett   CURRENT OPINION IN MICROBIOLOGY

Transsynaptic inhibition of spinal transmission by A2 botulinum toxin

(2012) Norio Akaike et al.   JOURNAL OF PHYSIOLOGY-LONDON

Current and future medical treatment in primary dystonia

(2012) Cathérine C.S. Delnooz et al.   Therapeutic Advances in Neurological Disorders

An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial

(2011) S Hesse et al.   CLINICAL REHABILITATION

GABA and central neuropathic pain following spinal cord injury

(2011) Young S. Gwak et al.   NEUROPHARMACOLOGY

The place of the botulinum toxin in the management of multiple sclerosis

(2010) Mario Habek et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection

(2010) Lidija Bach-Rojecky et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain

(2010) Wei Cheong Ngeow et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Subcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia

(2010) Lizu Xiao et al.   PAIN MEDICINE

Botulinum Toxin A for Treatment of Allodynia of Complex Regional Pain Syndrome: A Pilot Study

(2010) Delaram Safarpour et al.   PAIN MEDICINE

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia

(2010) Daniel Truong et al.   PARKINSONISM & RELATED DISORDERS

Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models

(2009) Christine Favre-Guilmard et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes

(2009) P McCrory et al.   JOURNAL OF REHABILITATION MEDICINE

Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial

(2009) R. Y. Yuan et al.   NEUROLOGY

Long-Distance Retrograde Effects of Botulinum Neurotoxin A

(2008) F. Antonucci et al.   JOURNAL OF NEUROSCIENCE

Intramuscular Botulinum Toxin-A Reduces Hemiplegic Shoulder Pain

(2007) Jae-Young Lim et al.   STROKE